Point-of-care technology for STI diagnosis funded £16.9m
Atlas Genetics, a UK diagnostic company developing ultra-rapid point-of-care tests for infectious diseases, has raised £16.9m from a syndicate of new and existing investors.

According to Atlas, the £16.9m investment, which will be drawn down over three years, will be used to accelerate the global launch of the Velox point-of-care products for Chlamydia and gonorrhoea. It will also be used for the development of other infectious-disease tests and expand the immunoassay capability of the Velox system.
Velox is said to be a highly novel molecular diagnostic system for the ultra-rapid diagnosis of a range of infectious diseases using either nucleic acid or immuno assays and is based on a patent-protected electrochemical sensor.
It is claimed that the Velox system will make it possible, for the first time, to carry out infectious-disease tests in primary-care clinics and GP surgeries that are as accurate as those carried out in hospital laboratories.
The new investors in this series-B financing are Novartis Venture Funds, LSP (Life Sciences Partners), BB Biotech Ventures and Johnson and Johnson Development.
Florent Gros, managing director, Novartis Venture Funds, said: ‘We have searched long and hard for novel molecular diagnostic technologies and the Velox platform is a very ingenious solution to the key issues that have hindered the development of ultra-rapid and highly sensitive point-of-care molecular diagnostic instrumentation.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
WildFusion helps robot traverse difficult terrain
Son of Daleks? can they climb stairs?